-
Anaergia Inc. (ANRG $2.57)
- $2.57 Cap: $437M
- View ANRG Profile
- View Questions on ANRG
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Anaergia Inc. (ANRG $2.57)
- $2.57 Cap: $437M
- View ANRG Profile
- View Questions on ANRG
Q: A company that was showing good potential a few years ago but then flamed out. Near death, but seems to be on back on track. Could you confirm the insider buying also any positives or negatives... would you endorse buying ANRG.TO
-
Superior Plus Corp. (SPB $8.03)
- $8.03 P/E (TTM): 32.03X Cap: $1.80B
- View SPB Profile
- View Questions on SPB
-
Anaergia Inc. (ANRG $2.57)
- $2.57 Cap: $437M
- View ANRG Profile
- View Questions on ANRG
Q: Please comment on their earnings and outlook going forward. Please rate as a buy, hold or sell.
-
Intermap Technologies Corporation (IMP $2.33)
- $2.33 P/E (TTM): 176.95X Cap: $140M
- View IMP Profile
- View Questions on IMP
-
Medicenna Therapeutics Corp. (MDNA $1.38)
- $1.38 Cap: $115M
- View MDNA Profile
- View Questions on MDNA
-
Perpetua Resources Corp. (PPTA $32.35)
- $32.35 Cap: $3.47B
- View PPTA Profile
- View Questions on PPTA
-
Anaergia Inc. (ANRG $2.57)
- $2.57 Cap: $437M
- View ANRG Profile
- View Questions on ANRG
Q: Big speculative winners this year. Any merit for continuation in 2025? Thanks...
Insiders
Share Information
News and Media